These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31600973)

  • 1. Effect of Zinc Supplementation on Renal Anemia in 5/6-Nephrectomized Rats and a Comparison with Treatment with Recombinant Human Erythropoietin.
    Feng HL; Chen YH; Jeng SS
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to erythropoietin in pediatric patients with chronic kidney disease: insights from an in vitro bioassay.
    Gavish R; Watad S; Ben-Califa N; Goldberg OJ; Haskin O; Davidovits M; Koren G; Falush Y; Neumann D; Krause I
    Pediatr Nephrol; 2018 Nov; 33(11):2123-2129. PubMed ID: 30030607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia.
    Landau D; London L; Bandach I; Segev Y
    PLoS One; 2018; 13(5):e0196684. PubMed ID: 29738538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc Supplementation Stimulates Red Blood Cell Formation in Rats.
    Chen YH; Feng HL; Jeng SS
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30231592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemia.
    Piron M; Loo M; Gothot A; Tassin F; Fillet G; Beguin Y
    Blood; 2001 Jan; 97(2):442-8. PubMed ID: 11154221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to Recombinant Human Erythropoietin Therapy in a Rat Model of Chronic Kidney Disease Associated Anemia.
    Garrido P; Ribeiro S; Fernandes J; Vala H; Rocha-Pereira P; Bronze-da-Rocha E; Belo L; Costa E; Santos-Silva A; Reis F
    Int J Mol Sci; 2015 Dec; 17(1):. PubMed ID: 26712750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral Zinc-Rich Oyster Supplementation Corrects Anemia in Rats.
    Chen YH; Feng HL; Lu YC; Jeng SS
    Nutrients; 2023 Nov; 15(21):. PubMed ID: 37960326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of anemia in W/WV mice by recombinant human erythropoietin (rHuEPO) mediated through EPO receptors with lowered affinity.
    Kabaya K; Akiyama H; Nishi N; Misaizu T; Okada Y; Kawagishi M; Amano K; Kusaka M; Seki M; Uzumaki H
    Life Sci; 1995; 57(11):1067-76. PubMed ID: 7658914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal anemia: from incurable to curable.
    Sato Y; Yanagita M
    Am J Physiol Renal Physiol; 2013 Nov; 305(9):F1239-48. PubMed ID: 23884144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JTZ-951 (enarodustat), a hypoxia-inducible factor prolyl hydroxylase inhibitor, improves iron utilization and anemia of inflammation: Comparative study against recombinant erythropoietin in rat.
    Shinozaki Y; Fukui K; Kobayashi H; Yoshiuchi H; Matsuo A; Matsushita M
    Eur J Pharmacol; 2021 May; 898():173990. PubMed ID: 33657422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological and molecular mechanisms underlying resistance to recombinant human erythropoietin therapy in the remnant kidney rat model of chronic kidney disease associated anemia.
    Ribeiro S; Garrido P; Fernandes J; Vala H; Rocha-Pereira P; Costa E; Belo L; Reis F; Santos-Silva A
    Biochimie; 2016 Jun; 125():150-62. PubMed ID: 27039028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of purified recombinant human erythropoietin on anemia in rats with experimental renal failure induced by five-sixth nephrectomy.
    Kawamura A; Higuchi M; Imai N; Kawaguchi T; Ogura Y
    Biotherapy; 1990; 2(1):77-85. PubMed ID: 2400629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red blood cell lifespan in long-term hemodialysis patients treated with roxadustat or recombinant human erythropoietin.
    Yang X; Zhao B; Wang J; Wang L; Tao M; Lu J; Lin J; Sun J; Wang R
    Ren Fail; 2021 Dec; 43(1):1428-1436. PubMed ID: 34657570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of anemia in chronic renal failure by a long-activing activator of erythropoiesis].
    Ureña P
    Presse Med; 2002 Mar; 31(11):505-14. PubMed ID: 11963378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Combination Therapy of Erythropoietin and Thrombopoietin to Treat Erythropoietin-Resistance anemia.
    Zou H; Xu P; Wong RSM; Yan X
    Pharm Res; 2022 Jun; 39(6):1249-1265. PubMed ID: 35661082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble Fas affects erythropoiesis in vitro and acts as a potential predictor of erythropoiesis-stimulating agent therapy in patients with chronic kidney disease.
    Chiloff DM; de Almeida DC; Dalboni MA; Canziani ME; George SK; Morsi AM; El-Akabawy N; Porada CD; Durao MS; Zarjou A; Almeida-Porada G; Goes MA
    Am J Physiol Renal Physiol; 2020 Apr; 318(4):F861-F869. PubMed ID: 32003597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietic action of dexamethasone on the anemia associated with an experimental chronic renal failure.
    Malgor LA; Barrios L; de Albarenque MV; Verges E; de Markowsky EE; Montiel E; Mussin SM
    Acta Physiol Pharmacol Latinoam; 1987; 37(3):365-76. PubMed ID: 3503475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematide is immunologically distinct from erythropoietin and corrects anemia induced by antierythropoietin antibodies in a rat pure red cell aplasia model.
    Woodburn KW; Fan Q; Winslow S; Chen MJ; Mortensen RB; Casadevall N; Stead RB; Schatz PJ
    Exp Hematol; 2007 Aug; 35(8):1201-8. PubMed ID: 17662888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of erythropoietin-gene electrotransfer in rats with adenine-induced renal failure.
    Ataka K; Maruyama H; Neichi T; Miyazaki J; Gejyo F
    Am J Nephrol; 2003; 23(5):315-23. PubMed ID: 12915775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human recombinant erythropoietin reduces sensorimotor dysfunction and cognitive impairment in rat models of chronic kidney disease.
    Reza-Zaldívar EE; Sandoval-Avila S; Gutiérrez-Mercado YK; Vázquez-Méndez E; Canales-Aguirre AA; Esquivel-Solís H; Gómez-Pinedo U; Márquez-Aguirre AL
    Neurologia (Engl Ed); 2020 Apr; 35(3):147-154. PubMed ID: 29132915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.